-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$66.0029.13% Upside
Amphastar Pharmaceuticals, Inc. Frequently Asked Questions
-
What analysts cover Amphastar Pharmaceuticals, Inc.?
Amphastar Pharmaceuticals, Inc. has been rated by research analysts at Piper Sandler in the past 90 days.